Linked infacebooktwitteryoutube
Mankind Pharma

Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne muscular dystrophy

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

Bristol Myers Squibb

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Singular Genomics

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EGFR

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma Ltd

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

RNA therapies

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Macrogen

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

Gene therapy

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS, Delhi

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

Arbor Biotechnologies™

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Agilus Diagnostics

Fortis Healthcare Acquires Stake in Agilus Diagnostics